PubMed

Overexpression of GLUT5 in diabetic muscle is reversed by pioglitazone.

Stuart CA, Howell ME, Yin D.

Diabetes Care. 2007 Apr;30(4):925-31. Epub 2007 Jan 24.PMID: 17251278 [PubMed - indexed for MEDLINE]Related articlesFree article

Hexose transporter mRNAs for GLUT4, GLUT5, and GLUT12 predominate in human muscle.

Stuart CA, Yin D, Howell ME, Dykes RJ, Laffan JJ, Ferrando AA.

Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E1067-73. Epub 2006 Jun 27.PMID: 16803853 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone stimulates AMP-activated protein kinase signalling and increases the expression of genes involved in adiponectin signalling, mitochondrial function and fat oxidation in human skeletal muscle in vivo: a randomised trial.

Coletta DK, Sriwijitkamol A, Wajcberg E, Tantiwong P, Li M, Prentki M, Madiraju M, Jenkinson CP, Cersosimo E, Musi N, Defronzo RA.

Diabetologia. 2009 Apr;52(4):723-32. Epub 2009 Jan 24.PMID: 19169664 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.

Sourij H, Zweiker R, Wascher TC.

Diabetes Care. 2006 May;29(5):1039-45.PMID: 16644634 [PubMed - indexed for MEDLINE]Related articlesFree article

The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.

Tooke JE, Elston LM, Gooding KM, Ball CI, Mawson DM, Piper J, Sriraman R, Urquhart R, Shore AC.

Diabetologia. 2006 May;49(5):1064-70. Epub 2006 Mar 1.PMID: 16508777 [PubMed - indexed for MEDLINE]Related articles

The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo.

Bogacka I, Xie H, Bray GA, Smith SR.

Diabetes Care. 2004 Jul;27(7):1660-7.PMID: 15220243 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.

Fernandez M, Triplitt C, Wajcberg E, Sriwijilkamol AA, Musi N, Cusi K, DeFronzo R, Cersosimo E.

Diabetes Care. 2008 Jan;31(1):121-7. Epub 2007 Oct 1.PMID: 17909084 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.

Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA.

J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. Epub 2007 Jun 26.PMID: 17595259 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.

Basu R, Shah P, Basu A, Norby B, Dicke B, Chandramouli V, Cohen O, Landau BR, Rizza RA.

Diabetes. 2008 Jan;57(1):24-31. Epub 2007 Oct 3.PMID: 17914032 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment.

Schrauwen P, Mensink M, Schaart G, Moonen-Kornips E, Sels JP, Blaak EE, Russell AP, Hesselink MK.

J Clin Endocrinol Metab. 2006 Apr;91(4):1520-5. Epub 2005 Dec 29.PMID: 16384852 [PubMed - indexed for MEDLINE]Related articlesFree article

Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.

Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.

Metabolism. 2008 Nov;57(11):1552-7.PMID: 18940393 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.

Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.

Metabolism. 2007 Oct;56(10):1418-24.PMID: 17884455 [PubMed - indexed for MEDLINE]Related articles

Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.

Serlie MJ, Allick G, Groener JE, Ackermans MT, Heijligenberg R, Voermans BC, Aerts JM, Meijer AJ, Sauerwein HP.

J Clin Endocrinol Metab. 2007 Jan;92(1):166-71. Epub 2006 Oct 24.PMID: 17062758 [PubMed - indexed for MEDLINE]Related articlesFree article

GLUT11, but not GLUT8 or GLUT12, is expressed in human skeletal muscle in a fibre type-specific pattern.

Gaster M, Handberg A, Schürmann A, Joost HG, Beck-Nielsen H, Schrøder HD.

Pflugers Arch. 2004 Apr;448(1):105-13. Epub 2003 Dec 24.PMID: 14704796 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes.

Heliövaara MK, Herz M, Teppo AM, Leinonen E, Ebeling P.

J Endocrinol Invest. 2007 Apr;30(4):292-7.PMID: 17556865 [PubMed - indexed for MEDLINE]Related articles

2-year effects of pioglitazone add-on to sulfonylurea or metformin on oral glucose tolerance in patients with type 2 diabetes.

Seufert J, Urquhart R.

Diabetes Res Clin Pract. 2008 Mar;79(3):453-60. Epub 2007 Dec 26.PMID: 18160120 [PubMed - indexed for MEDLINE]Related articles

Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion.

Carey AL, Petersen EW, Bruce CR, Southgate RJ, Pilegaard H, Hawley JA, Pedersen BK, Febbraio MA.

Diabetologia. 2006 May;49(5):1000-7. Epub 2006 Mar 15.PMID: 16538490 [PubMed - indexed for MEDLINE]Related articles

Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF.

Diabetes. 2008 Feb;57(2):357-66. Epub 2007 Oct 31.PMID: 17977950 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone.

Hofmann C, Lorenz K, Colca JR.

Endocrinology. 1991 Oct;129(4):1915-25.PMID: 1915075 [PubMed - indexed for MEDLINE]Related articles

Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis.

Abe M, Kikuchi F, Kaizu K, Matsumoto K.

Clin Nephrol. 2007 Nov;68(5):287-94.PMID: 18044260 [PubMed - indexed for MEDLINE]Related articles